Literature DB >> 2691273

New trends in Mediterranean spotted fever.

F Segura-Porta1, B Font-Creus, E Espejo-Arenas, F Bella-Cueto.   

Abstract

Mediterranean Spotted Fever is a disease caused by Rickettsia conorii. It is endemic to the Mediterranean area, where, for the last few years, the number of cases has increased, possibly due, in part, to climatic factors. The main clinical aspects of a prospective series of 246 cases diagnosed from 1983 to 1988 are presented. The most characteristic manifestations were fever, exanthema and tache noire. Other frequent manifestations were headache, myalgia and arthralgia, and with lesser frequency, hepatomegaly, splenomegaly, gastrointestinal symptoms and conjunctivitis. Notable analytical changes are the rise of hepatic and muscular enzymes in a large number of patients. In some cases we have found signs of myositis in muscular biopsy. The evolution of our patients was usually favorable though serious and even deadly forms of the disease have been described. One of the factors that seems to greatly influence the appearance of these forms is delay in the initiation of effective treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2691273     DOI: 10.1007/bf00140137

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  37 in total

1.  The complement system in Mediterranean spotted fever.

Authors:  J I Herrero-Herrero; R Ruiz-Beltran; J Batlle-Forondona
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

2.  [Myositis in mediterranean boutonneuse fever].

Authors:  M Martínez de Albaladejo
Journal:  An Med Interna       Date:  1989-01

3.  Boutonneuse fever in American travelers.

Authors:  R L Harris; S L Kaplan; M W Bradshaw; T W Williams
Journal:  J Infect Dis       Date:  1986-01       Impact factor: 5.226

4.  Circulating immune complexes in Fièvre boutonneuse.

Authors:  G Tringali; S Mansueto
Journal:  Ann Trop Med Parasitol       Date:  1985-06

Review 5.  Mediterranean spotted fever: a cooperative study of 227 cases.

Authors:  B Font-Creus; F Bella-Cueto; E Espejo-Arenas; R Vidal-Sanahuja; T Muñoz-Espin; M Nolla-Salas; A Casagran-Borrell; J Mercade-Cuesta; F Segura-Porta
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

6.  Resurgence of Mediterranean spotted fever.

Authors: 
Journal:  Lancet       Date:  1982-11-13       Impact factor: 79.321

7.  Laboratory diagnosis of Mediterranean spotted fever by immunofluorescent demonstration of Rickettsia conorii in cutaneous lesions.

Authors:  D Raoult; C de Micco; H Gallais; M Toga
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

8.  Glucose-6-phosphate dehydrogenase deficiency in male patients with Mediterranean spotted fever in Sardinia.

Authors:  M A Piras; G Calia; F Saba; C Gakis; G Andreoni
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

9.  Demonstration of spotted fever group rickettsiae in the tache noire of a healthy person in Sicily.

Authors:  S Mansueto; G Tringali; R Di Leo; M Maniscalco; M R Montenegro; D H Walker
Journal:  Am J Trop Med Hyg       Date:  1984-05       Impact factor: 2.345

10.  [Hepatic involvement in boutonneuse fever (author's transl)].

Authors:  J García San Miguel; E Soriano; M Bruguera; A Martínez Vea; J Vivancos; A Urbano Márquez
Journal:  Med Clin (Barc)       Date:  1979-03-10       Impact factor: 1.725

View more
  13 in total

1.  Isolation and identification of Rickettsia massiliae from Rhipicephalus sanguineus ticks collected in Arizona.

Authors:  Marina E Eremeeva; Elizabeth A Bosserman; Linda J Demma; Maria L Zambrano; Dianna M Blau; Gregory A Dasch
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

2.  Mediterranean spotted fever in Marseille: descriptive epidemiology and the influence of climatic factors.

Authors:  D Raoult; H Tissot Dupont; P Caraco; P Brouqui; M Drancourt; C Charrel
Journal:  Eur J Epidemiol       Date:  1992-03       Impact factor: 8.082

Review 3.  Antimicrobial therapy of rickettsial diseases.

Authors:  D Raoult; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

4.  The role of the World Health Organization in the control of rickettsial diseases.

Authors:  Y Pervikov
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

5.  Phenotypic and genotypic characterization of spotted fever group Rickettsiae isolated from Catalan Rhipicephalus sanguineus ticks.

Authors:  L Beati; V Roux; A Ortuño; J Castella; F S Porta; D Raoult
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

6.  Prevalence of antibodies to spotted fever group rickettsiae along the eastern coast of the Adriatic sea.

Authors:  S Radulovic; D H Walker; K Weiss; B Dzelalija; M Morovic
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

7.  Western blot as a seroepidemiologic tool for detecting foci of Mediterranean spotted fever (MSF).

Authors:  D Raoult; J P Arzouni; M C Jambon; J Beytout; O Ramousse
Journal:  Eur J Epidemiol       Date:  1994-02       Impact factor: 8.082

Review 8.  Epidemiology of rickettsial diseases.

Authors:  D H Walker; D B Fishbein
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

9.  Arthritis in Mediterranean spotted fever.

Authors:  J Pedro-Botet; T Auguet; O Pallás; J L Gimeno
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

10.  Epidemiological study of rickettsial infections in patients with hypertransaminemia in Madrid (Spain).

Authors:  Lourdes Lledó; Rosario González; María Isabel Gegúndez; María Beltrán; José Vicente Saz
Journal:  Int J Environ Res Public Health       Date:  2009-09-28       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.